In memory of Newry's brave leukaemia fighter, Daniel Greer, a family member will now be tackling a mammoth cycle to raise ...

Acute Myeloid Leukemia (AML) is a hematological malignancy characterized by the rapid, uncontrolled growth of immature myeloid cells, leading to bone marrow ...

A stem cell treatment company claimed their stem cell therapies could reverse aging and treat, cure or prevent conditions such as Alzheimer's or COPD.

NEW YORK - IN8bio, Inc. (NASDAQ:INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies, reported ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

IN8bio (INAB) announced new clinical data from the ongoing Phase 1 investigator-sponsored trial of INB-100, an allogeneic gamma-delta T cell ...

In recent days, the Armenian Bone Marrow Donor Registry (ABMDR) held two donor recruitment drives in the Los Angeles area, to ...

Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

New Drug Tested to Reduce Side Effect of 'Half-Matched' Stem Cell Transplants Dec ... has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth.

In recent days, the Armenian Bone Marrow Donor Registry held two donor recruitment drives in the Los Angeles area, to find donor matches for patients in the US and abroad who urgently need bone marrow ...